GILEAD SCIENCES, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31)
GILEAD SCIENCES, INC. (GILD) had Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) of -$3.33 million as of 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Notes › Investments
us-gaap:AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses1 · last filed 2012-05-04
- 2012-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) -$3.33M.
- 2011-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) -$35.08M; Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) as first filed $35.08M.
- 2011-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) $42.10M.
- 2011-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) $18.20M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) as first filed |
|---|---|---|
| 2012-03-31 | -$3.33M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | -$35.08M 10-Q · filed 2012-05-04 | $35.08M 10-K · filed 2012-02-23 |
| 2011-09-30 | $42.10M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $18.20M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $9.72M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |